Journal profile · Materials Science, Biomaterials
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY
ISSN 1073-1199 · UNITED STATES · Bimonthly · Founded 1994
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY: subscription journal; review 6–12 weeks (community reports); community-reported acceptance: easy.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY's largest topics are Hemoglobin structure and function, Erythrocyte Function and Pathophysiology and Pancreatic function and diabetes, together about 40.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Materials Science, Biomaterials
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hemoglobin structure and functionBiochemistry, Genetics and Molecular Biology27.5%
- Erythrocyte Function and PathophysiologyMedicine6.8%
- Pancreatic function and diabetesMedicine6.2%
- Heme Oxygenase-1 and Carbon MonoxideBiochemistry, Genetics and Molecular Biology5.5%
- Neonatal Health and BiochemistryMedicine5.5%
- Hemoglobinopathies and Related DisordersMedicine4.8%
- Nitric Oxide and Endothelin EffectsMedicine4.5%
- Electrochemical sensors and biosensorsEngineering3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 50OpenAlex ·
- i10-index
- 570OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Country or region
- UNITED STATES
- Frequency
- Bimonthly
- Founded
- 1994
- ISSN
- 1073-1199
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY
How long does peer review take at ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY open access, and what is the APC?
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .